Celldex (NASDAQ:CLDX) to Participate in Upcoming Investor Conferences

HAMPTON, N.J. — November 7, 2025 — Leads & Copy — Celldex management will participate in fireside chats at investor conferences in November and December.

The sessions include:

Guggenheim 2nd Annual Healthcare Innovation Conference
Tuesday, November 11 at 10:00 am ET

TD Cowen Immunology & Inflammation Summit
Thursday, November 13 at 9:30 am ET

8th Annual Evercore Healthcare Conference
Tuesday, December 2 at 3:00 pm ET

Live webcasts will be available on the “Events & Presentations” page of the “Investors” section of the Celldex website. Replays will be available for 90 days following the event.

Celldex is focused on immunology to deliver life-changing therapies, pursuing antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders.

Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com

Source: Celldex

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.